Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
3.12M
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
45M
-
Shares change
-
+13M
-
Total reported value, excl. options
-
$786M
-
Value change
-
+$224M
-
Number of buys
-
61
-
Number of sells
-
-14
-
Price
-
$17.48
Significant Holders of Passage BIO, Inc. - COMMON STOCK (PASG) as of Q1 2021
89 filings reported holding PASG - Passage BIO, Inc. - COMMON STOCK as of Q1 2021.
Passage BIO, Inc. - COMMON STOCK (PASG) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45M shares
.
Largest 10 shareholders include FMR LLC (8.07M shares), ORBIMED ADVISORS LLC (6.96M shares), FRAZIER MANAGEMENT LLC (5.01M shares), Versant Venture Management, LLC (4.96M shares), BlackRock Inc. (3M shares), New Leaf Venture Partners, L.L.C. (2.5M shares), BOXER CAPITAL, LLC (1.93M shares), STATE STREET CORP (1.79M shares), Vivo Capital, LLC (1.41M shares), and VANGUARD GROUP INC (1.36M shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.